CBER Close To Filling New Hire Spots
This article was originally published in The Pink Sheet Daily
Executive Summary
The center is 80 percent done with its personnel expansion; all of the new employees will help review submissions.
You may also be interested in...
FDA’s Good Review Management Practices To Debut In “Near Future”
Even as the agency wrestles with the transformation brought by FDAAA, shifts in how it processes NDAs may be the "most important," CDER official says.
DoJ, Congress Want Ad Oversight: FDA Sounds Ready To Respond
The Department of Justice's level of interest in drug industry promotional issues seems to be increasing, FDA Division of Drug Marketing, Advertising & Communications Director Tom Abrams told the Food & Drug Law Institute advertising and promotion conference Sept. 8
Pharma's Reform Bounce: How Big a Bounce Will $80 Bil. Buy?
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.